EUVIMEDEUVIMED entdecken
Crossref

Role of Antenatal IVIG in Improving Fetal Outcomes in Rh Isoimmunized Pregnancies: A Single-Centre Analysis

K Aparna Sharma, Vatsla Dadhwal, Tanisha Gupta, Anubhuti Rana

Fetal Diagnosis and Therapy · 21.07.2026 · 1-7

DOI: 10.1159/000553637 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Fetal Diagnosis and Therapy, online erschienen am 21.07.2026. Verfasst von K Aparna Sharma und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, New Delhi, India. Die Arbeit nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Rh isoimmunization remains a major cause of haemolytic disease of the fetus and newborn, particularly when fetal anaemia develops early in gestation. Antenatal intravenous immunoglobulin (IVIG) has been proposed to improve fetal outcomes, but evidence remains limited, especially from low- and middle-income settings.

Methods

This study was conducted at a tertiary care centre in India and included pregnant women with severe anti-D isoimmunization managed between 2023 and 2025. Inclusion criteria were pregnant women, with a previous pregnancy complicated by hydrops with perinatal death and/or requirement of intrauterine transfusion (IUT) before 24 weeks. They received antenatal IVIG (1 g/Kg/week from 13 to 14 weeks for 4–6 doses) and were compared with cases managed without IVIG. Outcomes analysed included presence of fetal hydrops, the requirement for IUT and the total number of IUTs, gestational age at first IUT, gestational age at delivery, and pregnancy outcome (live birth, stillbirth, or abortion) and neonatal outcomes.

Results

Thirty-four pregnancies were included with17 managed with IVIG and 17 managed without IVIG based on the timing of referral. The incidence of fetal hydrops was significantly lower in the IVIG group (5.9% vs. 52.9%, p = 0.008), and preterm delivery occurred less frequently (70.5% vs. 100%, p = 0.04). The need for IUT, gestational age at first IUT, number of IUTs, gestational age at delivery, and birth weight were comparable between groups. Live birth rate and survival at discharge were higher in the IVIG group, though differences did not reach statistical significance. Infusion-related reactions occurred in 17.6% of IVIG-treated patients and were mild.

Conclusion

Antenatal IVIG was associated with reduced fetal hydrops and preterm delivery in severe Rh isoimmunized pregnancies. However, these findings should be interpreted with caution as improved outcomes may also reflect earlier referral, surveillance, and intervention.

Schlagwörter

Stichwörter der Autor:innen

Fetal anaemiaIntrauterine transfusionRhesus isoimmunization

Autor:innen und Institutionen

  • Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, New Delhi, India.
  • Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, New Delhi, India, tanishagupta.tanu@gmail.com.

Zitieren

APA

Sharma, K. A., Dadhwal, V., Gupta, T., & Rana, A. (2026). Role of Antenatal IVIG in Improving Fetal Outcomes in Rh Isoimmunized Pregnancies: A Single-Centre Analysis. Fetal Diagnosis and Therapy, 1-7. https://doi.org/10.1159/000553637

Vancouver

Sharma KA, Dadhwal V, Gupta T, Rana A. Role of Antenatal IVIG in Improving Fetal Outcomes in Rh Isoimmunized Pregnancies: A Single-Centre Analysis. Fetal Diagnosis and Therapy. 2026:1-7. doi:10.1159/000553637

BibTeX
@article{Sharma2026,
  author = {Sharma, K Aparna and Dadhwal, Vatsla and Gupta, Tanisha and Rana, Anubhuti},
  title = {Role of Antenatal IVIG in Improving Fetal Outcomes in Rh Isoimmunized Pregnancies: A Single-Centre Analysis},
  journal = {Fetal Diagnosis and Therapy},
  year = {2026},
  pages = {1--7},
  doi = {10.1159/000553637}
}
Kostenlos starten →